2014 Q3 Form 10-K Financial Statement
#000114420414058476 Filed on September 30, 2014
Income Statement
Concept | 2014 Q3 | 2014 Q2 | 2014 |
---|---|---|---|
Revenue | $0.00 | $0.00 | $0.00 |
YoY Change | |||
Cost Of Revenue | |||
YoY Change | |||
Gross Profit | |||
YoY Change | |||
Gross Profit Margin | |||
Selling, General & Admin | $1.780M | $1.540M | $4.470M |
YoY Change | 157.97% | 52.48% | -26.24% |
% of Gross Profit | |||
Research & Development | $112.6K | $30.00K | $34.32K |
YoY Change | 882.17% | ||
% of Gross Profit | |||
Depreciation & Amortization | $27.40K | $10.00K | $7.759K |
YoY Change | |||
% of Gross Profit | |||
Operating Expenses | $2.235M | $2.230M | $5.176M |
YoY Change | 218.89% | 120.79% | -15.24% |
Operating Profit | -$2.235M | -$5.176M | |
YoY Change | 218.89% | -15.24% | |
Interest Expense | $500.00 | $220.0K | $4.230M |
YoY Change | -99.7% | -1200.0% | 643.61% |
% of Operating Profit | |||
Other Income/Expense, Net | $20.43K | -$4.554M | |
YoY Change | -117.22% | 633.9% | |
Pretax Income | -$2.210M | -$2.010M | -$9.730M |
YoY Change | 169.51% | 95.15% | 44.58% |
Income Tax | $0.00 | $0.00 | |
% Of Pretax Income | |||
Net Earnings | -$2.215M | -$2.010M | -$9.730M |
YoY Change | 170.24% | 95.15% | 44.64% |
Net Earnings / Revenue | |||
Basic Earnings Per Share | -$1.04 | ||
Diluted Earnings Per Share | -$6.139M | -$5.743M | -$1.04 |
COMMON SHARES | |||
Basic Shares Outstanding | 18.09M shares | 17.72M shares | 9.385M shares |
Diluted Shares Outstanding | 9.385M shares |
Balance Sheet
Concept | 2014 Q3 | 2014 Q2 | 2014 |
---|---|---|---|
SHORT-TERM ASSETS | |||
Cash & Short-Term Investments | $4.300M | $5.930M | $5.930M |
YoY Change | |||
Cash & Equivalents | $4.300M | $5.930M | $5.930M |
Short-Term Investments | |||
Other Short-Term Assets | $95.88K | $83.43K | $80.00K |
YoY Change | 90.92% | -12.62% | -80.95% |
Inventory | $301.9K | $289.6K | $290.0K |
Prepaid Expenses | |||
Receivables | |||
Other Receivables | |||
Total Short-Term Assets | $4.696M | $6.308M | $6.310M |
YoY Change | 715.17% | 673.41% | 669.51% |
LONG-TERM ASSETS | |||
Property, Plant & Equipment | $812.2K | $337.9K | $340.0K |
YoY Change | 190.06% | 22.56% | 21.43% |
Goodwill | |||
YoY Change | |||
Intangibles | $9.161K | ||
YoY Change | |||
Long-Term Investments | |||
YoY Change | |||
Other Assets | $750.0K | $750.0K | $750.0K |
YoY Change | |||
Total Long-Term Assets | $1.571M | $1.097M | $1.090M |
YoY Change | 446.38% | 280.38% | 289.29% |
TOTAL ASSETS | |||
Total Short-Term Assets | $4.696M | $6.308M | $6.310M |
Total Long-Term Assets | $1.571M | $1.097M | $1.090M |
Total Assets | $6.267M | $7.405M | $7.400M |
YoY Change | 625.68% | 570.73% | 572.73% |
SHORT-TERM LIABILITIES | |||
YoY Change | |||
Accounts Payable | $700.0K | $460.3K | $860.0K |
YoY Change | 71.2% | 144.4% | -14.0% |
Accrued Expenses | $10.00K | $10.00K | $10.00K |
YoY Change | -97.87% | -97.37% | -97.37% |
Deferred Revenue | |||
YoY Change | |||
Short-Term Debt | $60.00K | $60.00K | $60.00K |
YoY Change | -98.39% | -98.39% | -98.39% |
Long-Term Debt Due | $80.00K | ||
YoY Change | |||
Total Short-Term Liabilities | $892.9K | $964.0K | $960.0K |
YoY Change | -84.28% | -81.69% | -81.78% |
LONG-TERM LIABILITIES | |||
Long-Term Debt | $100.0K | $0.00 | $0.00 |
YoY Change | |||
Other Long-Term Liabilities | $253.1K | $33.88K | $30.00K |
YoY Change | |||
Total Long-Term Liabilities | $354.8K | $33.88K | $30.00K |
YoY Change | |||
TOTAL LIABILITIES | |||
Total Short-Term Liabilities | $892.9K | $964.0K | $960.0K |
Total Long-Term Liabilities | $354.8K | $33.88K | $30.00K |
Total Liabilities | $1.248M | $997.9K | $1.000M |
YoY Change | -78.03% | -81.05% | -81.02% |
SHAREHOLDERS EQUITY | |||
Retained Earnings | -$17.75M | ||
YoY Change | |||
Common Stock | $18.22K | $18.09K | |
YoY Change | -54.46% | 171.37% | |
Preferred Stock | |||
YoY Change | |||
Treasury Stock (at cost) | |||
YoY Change | |||
Treasury Stock Shares | |||
Shareholders Equity | $5.019M | $6.407M | $6.410M |
YoY Change | |||
Total Liabilities & Shareholders Equity | $6.267M | $7.405M | $7.400M |
YoY Change | 625.68% | 570.73% | 572.73% |
Cashflow Statement
Concept | 2014 Q3 | 2014 Q2 | 2014 |
---|---|---|---|
OPERATING ACTIVITIES | |||
Net Income | -$2.215M | -$2.010M | -$9.730M |
YoY Change | 170.24% | 95.15% | 44.64% |
Depreciation, Depletion And Amortization | $27.40K | $10.00K | $7.759K |
YoY Change | |||
Cash From Operating Activities | -$1.470M | -$2.100M | -$3.170M |
YoY Change | -40143.58% | 813.04% | 94.72% |
INVESTING ACTIVITIES | |||
Capital Expenditures | -$170.0K | -$70.00K | -$70.00K |
YoY Change | -86.27% | ||
Acquisitions | |||
YoY Change | |||
Other Investing Activities | $0.00 | -$750.0K | -$760.0K |
YoY Change | -208.57% | ||
Cash From Investing Activities | -$170.0K | -$820.0K | -$830.0K |
YoY Change | 4821.83% | -548.37% | |
FINANCING ACTIVITIES | |||
Cash Dividend Paid | |||
YoY Change | |||
Common Stock Issuance & Retirement, Net | |||
YoY Change | |||
Debt Paid & Issued, Net | |||
YoY Change | |||
Cash From Financing Activities | 0.000 | 3.210M | 9.930M |
YoY Change | -2106.25% | 600.53% | |
NET CHANGE | |||
Cash From Operating Activities | -1.470M | -2.100M | -3.170M |
Cash From Investing Activities | -170.0K | -820.0K | -830.0K |
Cash From Financing Activities | 0.000 | 3.210M | 9.930M |
Net Change In Cash | -1.640M | 290.0K | 5.930M |
YoY Change | -755860.37% | -174.36% | -23491.58% |
FREE CASH FLOW | |||
Cash From Operating Activities | -$1.470M | -$2.100M | -$3.170M |
Capital Expenditures | -$170.0K | -$70.00K | -$70.00K |
Free Cash Flow | -$1.300M | -$2.030M | -$3.100M |
YoY Change | 782.61% | 177.29% |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2013Q2 | us-gaap |
Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
|
3732500 | USD |
CY2014 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" align="justify"><strong><i>Accounting Estimates</i></strong> - The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts in the financial statements and the accompanying notes. Such estimates and assumptions impact, among others, the following: estimated useful lives and potential impairment of intangible assets, the fair value of share-based payments and warrants, estimates of the probability and potential magnitude of contingent liabilities and the valuation allowance for deferred tax assets due to continuing and expected future operating losses. Actual results could differ from those estimates.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> | |
CY2013Q2 | us-gaap |
Other Assets Current
OtherAssetsCurrent
|
95469 | USD |
CY2013Q2 | us-gaap |
Assets Noncurrent
AssetsNoncurrent
|
288422 | USD |
CY2014Q2 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
337932 | USD |
CY2014Q2 | us-gaap |
Other Assets Current
OtherAssetsCurrent
|
83425 | USD |
CY2014Q2 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
0 | USD |
CY2013Q2 | us-gaap |
Common Stock Value
CommonStockValue
|
6667 | USD |
CY2014Q2 | us-gaap |
Common Stock Value
CommonStockValue
|
18092 | USD |
CY2013Q2 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
3847591 | USD |
CY2014Q2 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
24135563 | USD |
CY2013Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-4162212 | USD |
CY2014Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
6406731 | USD |
CY2013Q2 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
1103971 | USD |
CY2014Q2 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
7404652 | USD |
CY2014Q2 | us-gaap |
Cash
Cash
|
5934534 | USD |
CY2013Q2 | us-gaap |
Derivative Liabilities Current
DerivativeLiabilitiesCurrent
|
157761 | USD |
CY2013Q2 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
5266183 | USD |
CY2013Q2 | us-gaap |
Cash
Cash
|
527 | USD |
CY2013Q2 | us-gaap |
Notes Receivable Related Parties Current
NotesReceivableRelatedPartiesCurrent
|
163829 | USD |
CY2014Q2 | us-gaap |
Notes Receivable Related Parties Current
NotesReceivableRelatedPartiesCurrent
|
0 | USD |
CY2013Q2 | us-gaap |
Interest Receivable Current
InterestReceivableCurrent
|
3341 | USD |
CY2014Q2 | us-gaap |
Interest Receivable Current
InterestReceivableCurrent
|
0 | USD |
CY2013Q2 | us-gaap |
Inventory Net
InventoryNet
|
223000 | USD |
CY2014Q2 | us-gaap |
Inventory Net
InventoryNet
|
289600 | USD |
CY2013Q2 | us-gaap |
Related Party Transaction Due From To Related Party Current
RelatedPartyTransactionDueFromToRelatedPartyCurrent
|
183346 | USD |
CY2014Q2 | us-gaap |
Related Party Transaction Due From To Related Party Current
RelatedPartyTransactionDueFromToRelatedPartyCurrent
|
0 | USD |
CY2013Q2 | us-gaap |
Deferred Finance Costs Current Net
DeferredFinanceCostsCurrentNet
|
146037 | USD |
CY2014Q2 | us-gaap |
Deferred Finance Costs Current Net
DeferredFinanceCostsCurrentNet
|
0 | USD |
CY2013Q2 | us-gaap |
Assets Current
AssetsCurrent
|
815549 | USD |
CY2014Q2 | us-gaap |
Assets Current
AssetsCurrent
|
6307559 | USD |
CY2013Q2 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
275717 | USD |
CY2013Q2 | us-gaap |
Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
|
12705 | USD |
CY2014Q2 | us-gaap |
Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
|
9161 | USD |
CY2014Q2 | us-gaap |
Assets Noncurrent
AssetsNoncurrent
|
1097093 | USD |
CY2013Q2 | us-gaap |
Assets
Assets
|
1103971 | USD |
CY2014Q2 | us-gaap |
Assets
Assets
|
7404652 | USD |
CY2013Q2 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
188346 | USD |
CY2014Q2 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
460311 | USD |
CY2013Q2 | us-gaap |
Due To Related Parties Current
DueToRelatedPartiesCurrent
|
807001 | USD |
CY2014Q2 | us-gaap |
Due To Related Parties Current
DueToRelatedPartiesCurrent
|
397055 | USD |
CY2014Q2 | us-gaap |
Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
|
60000 | USD |
CY2013Q2 | us-gaap |
Interest Payable Current
InterestPayableCurrent
|
380575 | USD |
CY2014Q2 | us-gaap |
Interest Payable Current
InterestPayableCurrent
|
11079 | USD |
CY2014Q2 | us-gaap |
Derivative Liabilities Current
DerivativeLiabilitiesCurrent
|
35595 | USD |
CY2014Q2 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
964040 | USD |
CY2013Q2 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
USD | |
CY2014Q2 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
USD | |
CY2013Q2 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
0 | USD |
CY2013Q2 | us-gaap |
Development Stage Enterprise Deficit Accumulated During Development Stage
DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage
|
8016470 | USD |
CY2014Q2 | us-gaap |
Development Stage Enterprise Deficit Accumulated During Development Stage
DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage
|
17746924 | USD |
CY2014 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
34317 | USD |
CY2014Q2 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
20000000 | shares |
CY2014Q2 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
CY2014Q2 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | shares |
CY2014Q2 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2014Q2 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
200000000 | shares |
CY2014Q2 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
18091792 | shares |
CY2014Q2 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
18091792 | shares |
CY2014 | us-gaap |
Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
|
Effective May 1, 2014, the Company effected a 6 to 1 reverse split of the Companys common stock, in which for every six (6) shares of common stock combined into one (1) share of common stock. | |
CY2013Q2 | us-gaap |
Financial Instruments Owned At Fair Value
FinancialInstrumentsOwnedAtFairValue
|
-157761 | USD |
CY2014 | antb |
Fair Value Of Financial Instruments Earnings
FairValueOfFinancialInstrumentsEarnings
|
336489 | USD |
CY2014 | antb |
Fair Value Of Financial Instruments Warrant Reclassified To Equity
FairValueOfFinancialInstrumentsWarrantReclassifiedToEquity
|
1407739 | USD |
CY2014Q2 | us-gaap |
Financial Instruments Owned At Fair Value
FinancialInstrumentsOwnedAtFairValue
|
-35595 | USD |
CY2013Q1 | antb |
Business Acquisition Purchase Price Allocation Current Assets Inventory1
BusinessAcquisitionPurchasePriceAllocationCurrentAssetsInventory1
|
223000 | USD |
CY2013Q1 | antb |
Business Acquisition Purchase Price Allocation Fixed Assets
BusinessAcquisitionPurchasePriceAllocationFixedAssets
|
264000 | USD |
CY2013Q1 | antb |
Business Acquisition Purchase Price Allocation Intangible Assets Other Than Goodwill1
BusinessAcquisitionPurchasePriceAllocationIntangibleAssetsOtherThanGoodwill1
|
13000 | USD |
CY2013Q1 | antb |
Business Acquisitions Cost Of Acquired Entity Purchase Price
BusinessAcquisitionsCostOfAcquiredEntityPurchasePrice
|
500000 | USD |
CY2013Q1 | us-gaap |
Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
|
400000 | USD |
CY2013Q1 | antb |
Business Acquisition Purchases Price Allocation Assets Acquired
BusinessAcquisitionPurchasesPriceAllocationAssetsAcquired
|
100000 | USD |
CY2013Q2 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.001 | |
CY2014Q2 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.001 | |
CY2013Q2 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
20000000 | shares |
CY2013Q2 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
CY2013Q2 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | shares |
CY2013Q2 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2013Q2 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
200000000 | shares |
CY2013Q2 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
6666667 | shares |
CY2013Q2 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
6666667 | shares |
CY2011Q3 | antb |
Line Of Credit Issued To Related Party
LineOfCreditIssuedToRelatedParty
|
1000000 | USD |
CY2014 | antb |
Fair Value Of Warrants
FairValueOfWarrants
|
35595 | USD |
CY2014 | us-gaap |
Line Of Credit Facility Interest Rate Description
LineOfCreditFacilityInterestRateDescription
|
The line of credit bears interest equal to the lower of 10%, or the Wall Street Journal Prime Rate (3.25% at June 30, 2013) plus 5%. | |
CY2013Q2 | us-gaap |
Line Of Credit Facility Interest Rate At Period End
LineOfCreditFacilityInterestRateAtPeriodEnd
|
0.0825 | pure |
CY2012Q4 | us-gaap |
Line Of Credit Facility Interest Rate During Period
LineOfCreditFacilityInterestRateDuringPeriod
|
0.05 | pure |
CY2014 | us-gaap |
Line Of Credit Facility Description
LineOfCreditFacilityDescription
|
The line of credit was for a period of one year and matured on August 31, 2012. | |
CY2013 | antb |
Consulting Expenses
ConsultingExpenses
|
598995 | USD |
CY2014 | antb |
Consulting Expenses
ConsultingExpenses
|
321205 | USD |
CY2013Q2 | antb |
Related Party Expenses
RelatedPartyExpenses
|
807001 | USD |
CY2014Q2 | antb |
Related Party Expenses
RelatedPartyExpenses
|
397055 | USD |
CY2013Q2 | us-gaap |
Due From Related Parties
DueFromRelatedParties
|
183346 | USD |
CY2013Q2 | us-gaap |
Line Of Credit
LineOfCredit
|
163829 | USD |
CY2014Q2 | us-gaap |
Line Of Credit
LineOfCredit
|
0 | USD |
CY2014Q2 | us-gaap |
Due From Related Parties
DueFromRelatedParties
|
0 | USD |
CY2013Q2 | us-gaap |
Debt Instrument Face Amount
DebtInstrumentFaceAmount
|
3732500 | USD |
CY2014Q2 | us-gaap |
Debt Instrument Face Amount
DebtInstrumentFaceAmount
|
60000 | USD |
CY2014Q2 | antb |
Third Party Capital Investment
ThirdPartyCapitalInvestment
|
2500000 | USD |
CY2011Q2 | antb |
Percentage Of Common Share Price Of Financing
PercentageOfCommonSharePriceOfFinancing
|
0.65 | pure |
CY2014 | antb |
Percentage Of Common Share Price Of Financing
PercentageOfCommonSharePriceOfFinancing
|
0.65 | pure |
CY2011Q2 | antb |
Maximum Convertible Notes Payable Issuance
MaximumConvertibleNotesPayableIssuance
|
2000000 | USD |
CY2012Q3 | antb |
Maximum Convertible Notes Payable Issuance
MaximumConvertibleNotesPayableIssuance
|
2000000 | USD |
CY2012Q4 | antb |
Maximum Convertible Notes Payable Issuance
MaximumConvertibleNotesPayableIssuance
|
1000000 | USD |
CY2011Q2 | antb |
Qualified Offering Common Stock
QualifiedOfferingCommonStock
|
5000000 | USD |
CY2011Q2 | antb |
Maximum Conversion Pre Money Valuation
MaximumConversionPreMoneyValuation
|
20000000 | USD |
CY2011Q2 | antb |
Percentage Of Exercise Per Share On Price Per Common Share
PercentageOfExercisePerShareOnPricePerCommonShare
|
1.35 | pure |
CY2012Q3 | antb |
Description Of Convertible Notes
DescriptionOfConvertibleNotes
|
On the maturity date of the convertible notes, or the closing of a Sale of the Company, whichever occurs first, the lenders are permitted an elective conversion option to convert the outstanding principal and interest on the convertible notes at the lower of 65% of the price per share of common stock in the Qualified Financing or 65% of the common stock price using a pre-money valuation of the Company of $20 million. | |
CY2012Q4 | antb |
Description Of Convertible Notes
DescriptionOfConvertibleNotes
|
On the date of a Qualified Financing, the lenders are permitted an elective conversion option to convert the outstanding principal and interest at the lower of 50% of the price per share of common stock in the Qualified Financing or $4.50 per share. | |
CY2012Q3 | antb |
Percentage Of Price Per Common Share On Warrant To Purchase Two Shares Of Common Stock
PercentageOfPricePerCommonShareOnWarrantToPurchaseTwoSharesOfCommonStock
|
1.35 | pure |
CY2012Q4 | antb |
Percentage Of Price Per Common Share On Warrant To Purchase One Share Of Common Stock
PercentageOfPricePerCommonShareOnWarrantToPurchaseOneShareOfCommonStock
|
1.5 | pure |
CY2012Q3 | us-gaap |
Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
|
0.08 | pure |
CY2012Q4 | us-gaap |
Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
|
0.08 | pure |
CY2013Q4 | us-gaap |
Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
|
0.08 | pure |
CY2013Q4 | us-gaap |
Debt Instrument Face Amount
DebtInstrumentFaceAmount
|
2703000 | USD |
CY2014 | antb |
Additional Warrants Issued
AdditionalWarrantsIssued
|
562352 | shares |
CY2013 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
1508334 | shares |
CY2014 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
2835000 | shares |
CY2013Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
1508334 | shares |
CY2014Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
4343334 | shares |
CY2014Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
|
1387871 | shares |
CY2012Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
0 | |
CY2013 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
|
4.50 | |
CY2014 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
|
3.14 | |
CY2013Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
4.50 | |
CY2014Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
3.61 | |
CY2014Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
|
4.33 | |
CY2012 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
|
P0Y | |
CY2013 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
|
P4Y7M6D | |
CY2014 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
|
P5Y7M6D | |
CY2014 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
|
P4Y | |
CY2013Q1 | antb |
Share Based Compensation Arrangement By Share Based Payment Award Options Shares Purchased Vested Immediately
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsSharesPurchasedVestedImmediately
|
819445 | shares |
CY2013 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
3687502 | USD |
CY2013Q1 | antb |
Share Based Compensation Arrangement By Share Based Payment Award Options Shares Purchased Vested Monthly
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsSharesPurchasedVestedMonthly
|
541667 | shares |
CY2013Q1 | antb |
Share Based Compensation Arrangement By Share Based Payment Award Options Shares Purchased Vested Monthly Term
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsSharesPurchasedVestedMonthlyTerm
|
P0Y | |
CY2013 | us-gaap |
Interest Paid
InterestPaid
|
0 | USD |
CY2014 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
1081792 | USD |
CY2014Q2 | us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
|
7756739 | USD |
CY2014Q1 | us-gaap |
Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
|
233334 | shares |
CY2014Q2 | us-gaap |
Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
|
41424 | shares |
CY2014Q2 | us-gaap |
Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
|
290861 | shares |
CY2014Q2 | us-gaap |
Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
|
290861 | shares |
CY2012Q2 | antb |
Proceeds From Issuance Of Stock Option To Purchase Of Common Stock
ProceedsFromIssuanceOfStockOptionToPurchaseOfCommonStock
|
3500000 | shares |
CY2013 | antb |
Consulting Fees
ConsultingFees
|
647925 | USD |
CY2014 | antb |
Consulting Fees
ConsultingFees
|
579817 | USD |
CY2013 | antb |
Payroll Expenses
PayrollExpenses
|
4485064 | USD |
CY2014 | antb |
Payroll Expenses
PayrollExpenses
|
2260598 | USD |
CY2013 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
3494 | USD |
CY2013 | us-gaap |
General Insurance Expense
GeneralInsuranceExpense
|
101276 | USD |
CY2014 | us-gaap |
General Insurance Expense
GeneralInsuranceExpense
|
154722 | USD |
CY2013 | us-gaap |
Professional Fees
ProfessionalFees
|
620162 | USD |
CY2014 | us-gaap |
Professional Fees
ProfessionalFees
|
724385 | USD |
CY2013 | us-gaap |
Lease And Rental Expense
LeaseAndRentalExpense
|
73256 | USD |
CY2014 | us-gaap |
Lease And Rental Expense
LeaseAndRentalExpense
|
134952 | USD |
CY2013 | antb |
Travel Expenses
TravelExpenses
|
90048 | USD |
CY2014 | antb |
Travel Expenses
TravelExpenses
|
106421 | USD |
CY2013 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
28660 | USD |
CY2014 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
475042 | USD |
CY2013 | us-gaap |
Operating Expenses
OperatingExpenses
|
6106881 | USD |
CY2014 | us-gaap |
Operating Expenses
OperatingExpenses
|
5176033 | USD |
CY2013 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-6106881 | USD |
CY2014 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-5176033 | USD |
CY2013 | us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
106044 | USD |
CY2014 | us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
12180 | USD |
CY2013 | us-gaap |
Interest Expense
InterestExpense
|
568859 | USD |
CY2014 | us-gaap |
Interest Expense
InterestExpense
|
4230112 | USD |
CY2013 | us-gaap |
Other General Expense
OtherGeneralExpense
|
157761 | USD |
CY2014 | us-gaap |
Other General Expense
OtherGeneralExpense
|
336489 | USD |
CY2013 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-620576 | USD |
CY2014 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-4554421 | USD |
CY2013 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-6727457 | USD |
CY2014 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-9730454 | USD |
CY2012Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-1288913 | USD |
CY2013 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
3687502 | USD |
CY2014 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
1081792 | USD |
CY2014 | us-gaap |
Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
|
2922938 | USD |
CY2013 | antb |
Class Of Warrant Or Right Expense
ClassOfWarrantOrRightExpense
|
191126 | USD |
CY2014 | antb |
Fair Value Of Warrants For Financing And Conversion
FairValueOfWarrantsForFinancingAndConversion
|
6476606 | USD |
CY2013 | us-gaap |
Stockholders Equity Note Spinoff Transaction
StockholdersEquityNoteSpinoffTransaction
|
-24470 | USD |
CY2014 | us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
3483408 | USD |
CY2014 | us-gaap |
Stock Issued During Period Value Conversion Of Units
StockIssuedDuringPeriodValueConversionOfUnits
|
4964879 | USD |
CY2014 | antb |
Stock Issued During Period Value Related Party
StockIssuedDuringPeriodValueRelatedParty
|
275000 | USD |
CY2013 | us-gaap |
Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
|
19312 | USD |
CY2014 | us-gaap |
Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
|
3356000 | USD |
CY2013 | us-gaap |
Amortization Of Financing Costs
AmortizationOfFinancingCosts
|
279096 | USD |
CY2014 | us-gaap |
Amortization Of Financing Costs
AmortizationOfFinancingCosts
|
416337 | USD |
CY2013 | us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
295 | USD |
CY2014 | us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
3544 | USD |
CY2013 | antb |
Warrant Expense
WarrantExpense
|
0 | USD |
CY2014 | antb |
Warrant Expense
WarrantExpense
|
126427 | USD |
CY2014 | us-gaap |
Increase Decrease In Interest And Dividends Receivable
IncreaseDecreaseInInterestAndDividendsReceivable
|
10211 | USD |
CY2013 | us-gaap |
Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
|
0 | USD |
CY2014 | us-gaap |
Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
|
341780 | USD |
CY2013 | us-gaap |
Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
|
-6706 | USD |
CY2014 | us-gaap |
Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
|
-12044 | USD |
CY2013 | antb |
Proceeds From Issuance Of Notes Receivable Related Party
ProceedsFromIssuanceOfNotesReceivableRelatedParty
|
-305603 | USD |
CY2014 | antb |
Proceeds From Issuance Of Notes Receivable Related Party
ProceedsFromIssuanceOfNotesReceivableRelatedParty
|
0 | USD |
CY2013 | antb |
Payment To Acquire Notes Receivable Related Parties
PaymentToAcquireNotesReceivableRelatedParties
|
-974228 | USD |
CY2014 | antb |
Payment To Acquire Notes Receivable Related Parties
PaymentToAcquireNotesReceivableRelatedParties
|
0 | USD |
CY2013 | us-gaap |
Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
|
185114 | USD |
CY2014 | us-gaap |
Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
|
-830185 | USD |
CY2014 | us-gaap |
Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
|
353091 | USD |
CY2013 | us-gaap |
Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
|
-1627965 | USD |
CY2014 | us-gaap |
Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
|
-3167357 | USD |
CY2013 | us-gaap |
Payments For Purchase Of Other Assets1
PaymentsForPurchaseOfOtherAssets1
|
11717 | USD |
CY2014 | us-gaap |
Payments For Purchase Of Other Assets1
PaymentsForPurchaseOfOtherAssets1
|
69974 | USD |
CY2013 | us-gaap |
Payments To Acquire Assets Investing Activities
PaymentsToAcquireAssetsInvestingActivities
|
500000 | USD |
CY2014 | us-gaap |
Payments To Acquire Assets Investing Activities
PaymentsToAcquireAssetsInvestingActivities
|
0 | USD |
CY2013 | us-gaap |
Increase Decrease In Interest And Dividends Receivable
IncreaseDecreaseInInterestAndDividendsReceivable
|
-28206 | USD |
CY2013 | us-gaap |
Payments Of Financing Costs
PaymentsOfFinancingCosts
|
157500 | USD |
CY2014 | us-gaap |
Payments Of Financing Costs
PaymentsOfFinancingCosts
|
270300 | USD |
CY2013 | us-gaap |
Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
|
1575000 | USD |
CY2014 | us-gaap |
Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
|
2703000 | USD |
CY2013 | us-gaap |
Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
|
0 | USD |
CY2014 | us-gaap |
Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
|
67500 | USD |
CY2013 | antb |
Proceeds From Issuance Of Notes Payable Related Party
ProceedsFromIssuanceOfNotesPayableRelatedParty
|
0 | USD |
CY2014 | antb |
Proceeds From Issuance Of Notes Payable Related Party
ProceedsFromIssuanceOfNotesPayableRelatedParty
|
234700 | USD |
CY2013 | us-gaap |
Increase Decrease In Due From Related Parties
IncreaseDecreaseInDueFromRelatedParties
|
206609 | USD |
CY2014 | us-gaap |
Increase Decrease In Due From Related Parties
IncreaseDecreaseInDueFromRelatedParties
|
-18947 | USD |
CY2013 | us-gaap |
Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
|
80117 | USD |
CY2014 | us-gaap |
Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
|
271965 | USD |
CY2013 | us-gaap |
Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
|
804861 | USD |
CY2014 | us-gaap |
Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
|
-134946 | USD |
CY2013 | us-gaap |
Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
|
270451 | USD |
CY2013 | us-gaap |
Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
|
0 | USD |
CY2014 | us-gaap |
Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
|
8931434 | USD |
CY2013 | us-gaap |
Payment Of Financing And Stock Issuance Costs
PaymentOfFinancingAndStockIssuanceCosts
|
0 | USD |
CY2014 | us-gaap |
Payment Of Financing And Stock Issuance Costs
PaymentOfFinancingAndStockIssuanceCosts
|
1365085 | USD |
CY2013 | us-gaap |
Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
|
1417500 | USD |
CY2014 | us-gaap |
Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
|
9931549 | USD |
CY2013 | us-gaap |
Cash Period Increase Decrease
CashPeriodIncreaseDecrease
|
-25351 | USD |
CY2014 | us-gaap |
Cash Period Increase Decrease
CashPeriodIncreaseDecrease
|
5934007 | USD |
CY2012Q2 | us-gaap |
Cash
Cash
|
25878 | USD |
CY2013 | us-gaap |
Income Taxes Paid
IncomeTaxesPaid
|
0 | USD |
CY2014 | us-gaap |
Income Taxes Paid
IncomeTaxesPaid
|
0 | USD |
CY2014 | us-gaap |
Interest Paid
InterestPaid
|
15726 | USD |
CY2013 | us-gaap |
Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1
NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1
|
1207 | USD |
CY2014 | us-gaap |
Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1
NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1
|
0 | USD |
CY2013 | antb |
Assumption Of Related Party In Reverse Merger
AssumptionOfRelatedPartyInReverseMerger
|
23263 | USD |
CY2014 | antb |
Assumption Of Related Party In Reverse Merger
AssumptionOfRelatedPartyInReverseMerger
|
0 | USD |
CY2013 | antb |
Conversion Of Convertible Notes Payable To Common Stock
ConversionOfConvertibleNotesPayableToCommonStock
|
0 | USD |
CY2014 | antb |
Conversion Of Convertible Notes Payable To Common Stock
ConversionOfConvertibleNotesPayableToCommonStock
|
6308000 | USD |
CY2013 | antb |
Conversion Of Interest Payable To Common Stock
ConversionOfInterestPayableToCommonStock
|
0 | USD |
CY2014 | antb |
Conversion Of Interest Payable To Common Stock
ConversionOfInterestPayableToCommonStock
|
722587 | USD |
CY2013 | antb |
Conversion Of Accounts Payable And Accrued Expense Related Party
ConversionOfAccountsPayableAndAccruedExpenseRelatedParty
|
0 | USD |
CY2014 | antb |
Conversion Of Accounts Payable And Accrued Expense Related Party
ConversionOfAccountsPayableAndAccruedExpenseRelatedParty
|
275000 | USD |
CY2013 | us-gaap |
Debt Instrument Convertible Beneficial Conversion Feature
DebtInstrumentConvertibleBeneficialConversionFeature
|
0 | USD |
CY2014 | us-gaap |
Debt Instrument Convertible Beneficial Conversion Feature
DebtInstrumentConvertibleBeneficialConversionFeature
|
2922938 | USD |
CY2013 | antb |
Warrant Value Recorded As Debt Discount
WarrantValueRecordedAsDebtDiscount
|
0 | USD |
CY2014 | antb |
Warrant Value Recorded As Debt Discount
WarrantValueRecordedAsDebtDiscount
|
433062 | USD |
CY2013 | us-gaap |
Noncash Or Part Noncash Acquisition Inventory Acquired1
NoncashOrPartNoncashAcquisitionInventoryAcquired1
|
223000 | USD |
CY2014 | us-gaap |
Noncash Or Part Noncash Acquisition Inventory Acquired1
NoncashOrPartNoncashAcquisitionInventoryAcquired1
|
0 | USD |
CY2013 | us-gaap |
Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
|
264000 | USD |
CY2014 | us-gaap |
Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
|
0 | USD |
CY2013 | antb |
Fair Value Of Financial Instruments Warrant Reclassified To Equity
FairValueOfFinancialInstrumentsWarrantReclassifiedToEquity
|
0 | USD |
CY2013 | us-gaap |
Noncash Or Part Noncash Acquisition Intangible Assets Acquired1
NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1
|
13000 | USD |
CY2014 | us-gaap |
Noncash Or Part Noncash Acquisition Intangible Assets Acquired1
NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1
|
0 | USD |
CY2013 | antb |
Cash Paid For Asset Acquisition
CashPaidForAssetAcquisition
|
500000 | USD |
CY2014 | antb |
Cash Paid For Asset Acquisition
CashPaidForAssetAcquisition
|
0 | USD |
CY2014 | us-gaap |
Nature Of Operations
NatureOfOperations
|
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" align="justify"><b><u>Note 1 Nature of Operations</u></b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" align="justify"><b> </b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" align="justify">These financial statements represent the consolidated financial statements of AntriaBio, Inc. (“AntriaBio”), formerly known as Fits My Style, Inc., and its wholly owned operating subsidiary, AntriaBio Delaware, Inc. (“Antria Delaware”). AntriaBio and Antria Delaware are collectively referred to herein as the “Company”.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" align="justify">On January 31, 2013, Antria Delaware merged with AntriaBio, a public company pursuant to a share exchange agreement in which the existing shareholders of Antria Delaware exchanged all of their issued and outstanding shares of common stock of Antria Delaware for <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 5,880,667</font> shares of common stock of AntriaBio (the “Reverse Merger”). After the consummation of the Reverse Merger, stockholders of Antria Delaware own <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 88.2</font>% of AntriaBio’s outstanding common stock.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" align="justify">As a result of the Reverse Merger, Antria Delaware became a wholly owned subsidiary of AntriaBio. For accounting purposes, the Reverse Merger was treated as a reverse acquisition with Antria Delaware as the acquirer and AntriaBio as the acquired party. As a result, the business and financial information included in this Annual Report on Form 10-K is the business and financial information of Antria Delaware. The accumulated deficit of AntriaBio has been included in additional paid-in-capital. Pro-forma information has not been presented as the financial information of AntriaBio was insignificant.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" align="justify"> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">Effective May 1, 2014, the Company effected a 6 to 1 reverse split of the Company’s common stock, in which for every six (6) shares of common stock combined into one (1) share of common stock.</font> All share and per share amounts have been retroactively restated to reflect the forward split.</div> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> | |
CY2014 | dei |
Document Type
DocumentType
|
10-K | |
CY2014 | dei |
Amendment Flag
AmendmentFlag
|
false | |
CY2014 | dei |
Document Period End Date
DocumentPeriodEndDate
|
2014-06-30 | |
CY2014 | dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2014 | |
CY2014 | dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
FY | |
CY2014 | dei |
Entity Registrant Name
EntityRegistrantName
|
AntriaBio, Inc. | |
CY2014 | dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001509261 | |
CY2014 | dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--06-30 | |
CY2014 | dei |
Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
|
No | |
CY2014 | dei |
Entity Voluntary Filers
EntityVoluntaryFilers
|
Yes | |
CY2014 | dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | |
CY2014 | dei |
Entity Filer Category
EntityFilerCategory
|
Smaller Reporting Company | |
CY2013Q4 | dei |
Entity Public Float
EntityPublicFloat
|
2768480 | USD |
CY2014 | dei |
Trading Symbol
TradingSymbol
|
ANTB | |
CY2014Q3 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
18091792 | shares |
CY2013Q2 | us-gaap |
Liabilities Noncurrent
LiabilitiesNoncurrent
|
0 | USD |
CY2014Q2 | us-gaap |
Liabilities Noncurrent
LiabilitiesNoncurrent
|
33881 | USD |
CY2013Q2 | us-gaap |
Liabilities
Liabilities
|
5266183 | USD |
CY2014Q2 | us-gaap |
Liabilities
Liabilities
|
997921 | USD |
CY2013 | us-gaap |
Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
|
0 | USD |
CY2013 | antb |
Meals And Entertainment Expenses
MealsAndEntertainmentExpenses
|
17670 | USD |
CY2014 | antb |
Meals And Entertainment Expenses
MealsAndEntertainmentExpenses
|
32562 | USD |
CY2014 | us-gaap |
Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
|
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> <strong><i>Reclassifications</i></strong> <i>–</i> Certain amounts reported in prior years in the Consolidated Financial Statements have been reclassified to conform to the current year’s presentation.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> | |
CY2013 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-1.08 | |
CY2014 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-1.04 | |
CY2013 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-1.08 | |
CY2014 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-1.04 | |
CY2013 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
6204568 | shares |
CY2014 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
9384662 | shares |
CY2013 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
6204568 | shares |
CY2014 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
9384662 | shares |
CY2013 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
0 | USD |
CY2014 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
0 | USD |
CY2013 | us-gaap |
Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
|
0 | USD |
CY2014 | us-gaap |
Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
|
0 | USD |
CY2013Q2 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
2468821 | USD |
CY2014Q2 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
4555200 | USD |
CY2013Q2 | us-gaap |
Deferred Tax Assets Net
DeferredTaxAssetsNet
|
0 | USD |
CY2014Q2 | us-gaap |
Deferred Tax Assets Net
DeferredTaxAssetsNet
|
0 | USD |
CY2013 | us-gaap |
Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
|
2293815 | USD |
CY2014 | us-gaap |
Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
|
3308354 | USD |
CY2014 | us-gaap |
Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
|
0 | USD |
CY2013 | us-gaap |
Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
|
0 | USD |
CY2014 | us-gaap |
Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
|
0 | USD |
CY2013 | us-gaap |
Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
|
2052267 | USD |
CY2014 | us-gaap |
Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
|
2006831 | USD |
CY2013 | us-gaap |
Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
|
184451 | USD |
CY2014 | us-gaap |
Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
|
79548 | USD |
CY2013 | us-gaap |
Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
|
2236718 | USD |
CY2014 | us-gaap |
Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
|
2086379 | USD |
CY2013 | us-gaap |
Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
|
0 | USD |
CY2014 | us-gaap |
Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
|
0 | USD |
CY2013Q2 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
|
562335 | USD |
CY2014Q2 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
|
2267379 | USD |
CY2013Q2 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Other
DeferredTaxAssetsTaxDeferredExpenseOther
|
580219 | USD |
CY2014Q2 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Other
DeferredTaxAssetsTaxDeferredExpenseOther
|
457495 | USD |
CY2013Q2 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
|
1265350 | USD |
CY2014Q2 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
|
1683247 | USD |
CY2013Q2 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Other
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther
|
60943 | USD |
CY2014Q2 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Other
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther
|
129986 | USD |
CY2013Q2 | us-gaap |
Deferred Tax Assets Other
DeferredTaxAssetsOther
|
-26 | USD |
CY2014Q2 | us-gaap |
Deferred Tax Assets Other
DeferredTaxAssetsOther
|
17093 | USD |
CY2013Q2 | us-gaap |
Deferred Tax Assets Gross
DeferredTaxAssetsGross
|
2468821 | USD |
CY2014Q2 | us-gaap |
Deferred Tax Assets Gross
DeferredTaxAssetsGross
|
4555200 | USD |
CY2013 | us-gaap |
Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
|
184451 | USD |
CY2014 | us-gaap |
Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
|
79549 | USD |
CY2013Q2 | us-gaap |
Accumulated Amortization Deferred Finance Costs
AccumulatedAmortizationDeferredFinanceCosts
|
362088 | USD |
CY2013 | antb |
Permenant Differences
PermenantDifferences
|
241548 | USD |
CY2014 | antb |
Permenant Differences
PermenantDifferences
|
1301524 | USD |
CY2014 | us-gaap |
Income Tax Examination Likelihood Of Unfavorable Settlement
IncomeTaxExaminationLikelihoodOfUnfavorableSettlement
|
An uncertain income tax position will not be recognized if it has less than a 50% likelihood of being sustained. | |
CY2014Q2 | us-gaap |
Operating Loss Carryforwards
OperatingLossCarryforwards
|
5869000 | USD |
CY2014 | antb |
Operating Loss Carryforwards Expiration Year
OperatingLossCarryforwardsExpirationYear
|
2031 | |
CY2014 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.34 | pure |
CY2014Q2 | us-gaap |
Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
|
262183 | USD |
CY2014Q2 | us-gaap |
Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
|
359468 | USD |
CY2014Q2 | us-gaap |
Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
|
370252 | USD |
CY2014Q2 | us-gaap |
Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
|
381360 | USD |
CY2014Q2 | us-gaap |
Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
|
392855 | USD |
CY2014Q2 | us-gaap |
Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
|
335747 | USD |
CY2014Q2 | us-gaap |
Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
|
2101865 | USD |
CY2014Q2 | antb |
Term Of Lease
TermOfLease
|
P72M | |
CY2014Q2 | us-gaap |
Lease And Rental Expense
LeaseAndRentalExpense
|
28939 | USD |
CY2014Q2 | antb |
Payments Of Monthly Lease Adjusted Annually Percentage
PaymentsOfMonthlyLeaseAdjustedAnnuallyPercentage
|
0.03 | pure |
CY2014Q2 | antb |
Adjusted Triple Net Expense Of Lease Payments
AdjustedTripleNetExpenseOfLeasePayments
|
36427 | USD |
CY2014 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
|
0.94 | pure |
CY2014 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
|
P7Y | |
CY2014 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
|
0 | pure |
CY2013Q2 | us-gaap |
Deposits Assets Noncurrent
DepositsAssetsNoncurrent
|
0 | USD |
CY2014Q2 | us-gaap |
Deposits Assets Noncurrent
DepositsAssetsNoncurrent
|
750000 | USD |
CY2013Q2 | antb |
Deferred Lease Liability Non Current
DeferredLeaseLiabilityNonCurrent
|
0 | USD |
CY2014Q2 | antb |
Deferred Lease Liability Non Current
DeferredLeaseLiabilityNonCurrent
|
33881 | USD |
CY2014Q2 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
|
1181 | USD |
CY2014Q2 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
|
1181 | USD |
CY2014Q2 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
|
1181 | USD |
CY2014Q2 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
|
1181 | USD |
CY2013 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
295 | USD |
CY2014 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
11303 | USD |
CY2014Q2 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
|
1181 | USD |
CY2014 | us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
0 | USD |
CY2014 | us-gaap |
Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
|
404587 | USD |
CY2013 | us-gaap |
Depreciation
Depreciation
|
0 | USD |
CY2014 | us-gaap |
Depreciation
Depreciation
|
7759 | USD |
CY2013 | us-gaap |
Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
|
0 | USD |
CY2014 | us-gaap |
Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
|
404587 | USD |
CY2013 | antb |
Deferred Lease Liability
DeferredLeaseLiability
|
0 | USD |
CY2014 | antb |
Deferred Lease Liability
DeferredLeaseLiability
|
33881 | USD |
CY2013 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
0 | USD |
CY2014 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
66600 | USD |
CY2013 | us-gaap |
Payments For Deposits
PaymentsForDeposits
|
0 | USD |
CY2014 | us-gaap |
Payments For Deposits
PaymentsForDeposits
|
750000 | USD |
CY2013 | us-gaap |
Repayments Of Notes Payable
RepaymentsOfNotesPayable
|
0 | USD |
CY2014 | us-gaap |
Repayments Of Notes Payable
RepaymentsOfNotesPayable
|
234700 | USD |
CY2013Q2 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
275717 | USD |
CY2014Q2 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
345691 | USD |
CY2013Q2 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
0 | USD |
CY2014Q2 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
7759 | USD |
CY2014Q2 | us-gaap |
Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
|
690187 | USD |
CY2014Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
|
41570 | shares |
CY2014 | antb |
Advertising Expenses For Common Stock
AdvertisingExpensesForCommonStock
|
404587 | USD |
CY2014Q1 | antb |
Services Agreement Expenses
ServicesAgreementExpenses
|
500000 | USD |
CY2014Q1 | us-gaap |
Area Of Land
AreaOfLand
|
27000 | sqft |
CY2013 | us-gaap |
Line Of Credit Facility Increase Accrued Interest
LineOfCreditFacilityIncreaseAccruedInterest
|
3341 | USD |
CY2014 | us-gaap |
Line Of Credit Facility Increase Accrued Interest
LineOfCreditFacilityIncreaseAccruedInterest
|
0 | USD |
CY2013Q2 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
|
138888 | shares |
CY2014Q2 | us-gaap |
Security Deposit
SecurityDeposit
|
750000 | USD |
CY2013 | antb |
Investor Relations
InvestorRelations
|
39031 | USD |
CY2014 | antb |
Investor Relations
InvestorRelations
|
661914 | USD |
CY2013 | antb |
Warrant Value Recorded As Issuance Costs
WarrantValueRecordedAsIssuanceCosts
|
0 | USD |
CY2014 | antb |
Warrant Value Recorded As Issuance Costs
WarrantValueRecordedAsIssuanceCosts
|
898719 | USD |
CY2014 | antb |
Warrants Recorded As Derivative Liability
WarrantsRecordedAsDerivativeLiability
|
-949084 | USD |
CY2014 | us-gaap |
Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
|
690187 | USD |